Acted for Blomfield Corporate Finance in relation to the successful fundraising by, and admission to trading on AIM of, Medgenics Inc, on 4 December. Admission to AIM follows the company's successful fund raising which raised a total of £3.276 million. Its market capitalisation at Admission was approximately £10.4 million.
Chris Chrysanthou and Allistair Booth of Fasken Martineau Stringer Saul acted for Blomfield Corporate Finance Limited in this matter.